awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58555802-4305A458-D1CB-407D-847E-DC10DFF63957
Q58555802-4305A458-D1CB-407D-847E-DC10DFF63957
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58555802-4305A458-D1CB-407D-847E-DC10DFF63957
Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in epidermal growth factor receptor-2-negative, mesenchymal-epithelial transition-positive gastroesophageal adenocarcinoma: is it a real failure?
P2860
Q58555802-4305A458-D1CB-407D-847E-DC10DFF63957
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58555802-4305A458-D1CB-407D-847E-DC10DFF63957
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b9deae6b406d9cdabababaf4687c0d65d6878b05
P2860
Randomized, phase II, placebo-controlled trial of onartuzumab and/or bevacizumab in combination with weekly paclitaxel in patients with metastatic triple-negative breast cancer.